Ownership history in VR Adviser, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in ASTRIA THERAPEUTICS INC (ATXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2,457,348 | — | 0% | 1.01% | $17.9M | $7.28 |
| 2025 Q2 | UNCHANGED | 2,457,348 | — | 0% | 0.99% | $13.2M | $5.36 |
| 2025 Q1 | UNCHANGED | 2,457,348 | — | 0% | 1.12% | $13.1M | $5.34 |
| 2024 Q4 | REDUCED | 2,457,348 | -1,001,297 | -29.0% | 1.51% | $22.0M | $8.94 |
| 2024 Q3 | REDUCED | 3,458,645 | -150,000 | -4.2% | 1.99% | $38.1M | $11.01 |
| 2024 Q2 | UNCHANGED | 3,608,645 | — | 0% | 2.09% | $32.8M | $9.10 |
| 2024 Q1 | ADDED | 3,608,645 | +382,839 | +11.9% | 2.42% | $50.8M | $14.07 |
| 2023 Q4 | ADDED | 3,225,806 | +2,686,807 | +498.5% | 1.70% | $24.8M | $7.68 |
| 2022 Q1 | UNCHANGED | 538,999 | — | 0% | 0.59% | $3.6M | $6.71 |
| 2021 Q4 | UNCHANGED | 538,999 | — | 0% | 0.40% | $2.9M | $5.39 |
As of 2025 Q4 — sorted by position size